Niranjan Kanesa-thasan

A live, attenuated recombinant West Nile virus vaccine

Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan et al. · Proceedings of the National Academy of Sciences · 2006 · 226 citations · Full text

Vaccination, Molecular Virology, Vaccine Development +12

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · 221 citations · Full text

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

Niranjan Kanesa-thasan, Wellington Sun, Gina Kim-Ahn et al. · Vaccine · 2001 · 218 citations

Vaccination, Vaccine Development, Human Volunteers +6

Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.

Scott B. Halstead, Thomas G. Streit, Jack Guy Lafontant et al. · American Journal of Tropical Medicine and Hygiene · 2001 · 211 citations

Vector-borne Pathogen, Infectious Disease Epidemiology, Dengue Resistance Gene +15

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison et al. · Human Vaccines · 2006 · 191 citations · Full text